ArticleOncoscience2020

Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer.

Emily M Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.